Talk to Us

Regence BlueShield of Washington prior authorization, page 9

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
81402Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and DosingCommercial Pre-authorization List, Pg 1 Original policy
81407Familial HypercholesterolemiaCommercial Pre-authorization List, Pg 1 Original policy
81275KRAS, NRAS and BRAF Variant Analysis and MicroRNA Expression Testing for Colorectal CancerCommercial Pre-authorization List, Pg 1 Original policy
81276KRAS, NRAS and BRAF Variant Analysis and MicroRNA Expression Testing for Colorectal CancerCommercial Pre-authorization List, Pg 1 Original policy
81311KRAS, NRAS and BRAF Variant Analysis and MicroRNA Expression Testing for Colorectal CancerCommercial Pre-authorization List, Pg 1 Original policy
81403KRAS, NRAS and BRAF Variant Analysis and MicroRNA Expression Testing for Colorectal CancerCommercial Pre-authorization List, Pg 1 Original policy
89290Preimplantation Genetic Testing of EmbryosCommercial Pre-authorization List, Pg 1 Original policy
89291Preimplantation Genetic Testing of EmbryosCommercial Pre-authorization List, Pg 1 Original policy
81228Preimplantation Genetic Testing of EmbryosCommercial Pre-authorization List, Pg 1 Original policy
81229Preimplantation Genetic Testing of EmbryosCommercial Pre-authorization List, Pg 1 Original policy
81349Preimplantation Genetic Testing of EmbryosCommercial Pre-authorization List, Pg 1 Original policy
0552UPreimplantation Genetic Testing of EmbryosCommercial Pre-authorization List, Pg 1 Original policy
81120IDH1 and IDH2 Genetic Testing for Conditions Other Than Myeloid Neoplasms or LeukemiaCommercial Pre-authorization List, Pg 1 Original policy
81121IDH1 and IDH2 Genetic Testing for Conditions Other Than Myeloid Neoplasms or LeukemiaCommercial Pre-authorization List, Pg 1 Original policy
81235Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81243Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81244Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81250Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81252Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81253Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81254Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81257Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81302Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81303Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81304Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81314Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81324Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81325Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81326Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81341Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81350Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81408Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81419Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81441Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81470Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81471Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3800Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3840Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3844Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3845Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3846Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3849Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3850Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3853Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3865Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
S3866Genetic and Molecular Diagnostic TestingCommercial Pre-authorization List, Pg 1 Original policy
81552Gene Expression Profiling for MelanomaCommercial Pre-authorization List, Pg 1 Original policy
81518Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast CancerCommercial Pre-authorization List, Pg 1 Original policy
81519Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast CancerCommercial Pre-authorization List, Pg 1 Original policy
81521Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast CancerCommercial Pre-authorization List, Pg 1 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.

This website uses cookies to ensure you get the best experience on our website. Learn more